Vaccinex, Inc. (NASDAQ:VCNX – Get Free Report) was the target of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 127,500 shares, an increase of 269.6% from the October 15th total of 34,500 shares. Based on an average daily trading volume, of 92,300 shares, the days-to-cover ratio is currently 1.4 days. Approximately 9.1% of the shares of the stock are short sold.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Vaccinex stock. AIGH Capital Management LLC raised its position in Vaccinex, Inc. (NASDAQ:VCNX – Free Report) by 86.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 108,958 shares of the company’s stock after purchasing an additional 50,593 shares during the quarter. AIGH Capital Management LLC owned 6.90% of Vaccinex worth $707,000 as of its most recent SEC filing. 50.11% of the stock is currently owned by institutional investors.
Vaccinex Price Performance
NASDAQ:VCNX traded up $0.19 during trading hours on Thursday, hitting $3.65. The company’s stock had a trading volume of 87,671 shares, compared to its average volume of 55,441. Vaccinex has a twelve month low of $1.39 and a twelve month high of $13.16. The stock has a fifty day simple moving average of $3.59 and a 200-day simple moving average of $5.17. The company has a market capitalization of $6.30 million, a P/E ratio of -0.06 and a beta of 0.98.
About Vaccinex
Vaccinex, Inc, a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D.
Featured Stories
- Five stocks we like better than Vaccinex
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- What Are Dividend Challengers?
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- Health Care Stocks Explained: Why You Might Want to Invest
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Vaccinex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vaccinex and related companies with MarketBeat.com's FREE daily email newsletter.
